Abstract:Pulmonary surfactant (PS), a complex mixture of lipids and proteins, is essential for maintaining proper lung function. It reduces surface tension in the alveoli, preventing collapse during expiration and facilitating re-expansion during inspiration. Additionally, PS has crucial roles in the respiratory system's innate defense and immune regulation. Dysfunction of PS contributes to various respiratory diseases, including neonatal respiratory distress syndrome (NRDS), adult respiratory distress syndrome (ARDS), COVID-19-associated ARDS, and ventilator-induced lung injury (VILI), among others. Furthermore, PS alterations play a significant role in chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). The intracellular stage involves storing and releasing a specialized subcellular organelle known as lamellar bodies (LB). The maturation of these organelles requires coordinated signaling to organize their intracellular organization in time and space. LB's intracellular maturation involves the lipid composition and critical processing of surfactant proteins to achieve proper functionality. Over a decade ago, the supramolecular organization of lamellar bodies was studied using electron microscopy. In recent years, novel bioimaging tools combining spectroscopy and microscopy have been utilized to investigate the in cellulo intracellular organization of lamellar bodies temporally and spatially. This short review provides an up-to-date understanding of intracellular LBs. Hyperspectral imaging and phasor analysis have allowed identifying specific transitions in LB's hydration, providing insights into their membrane dynamics and structure. A discussion and overview of the latest approaches that have contributed to a new comprehension of the trafficking and structure of lamellar bodies is presented.

[Pulmonary surfactant homeostasis associated genetic abnormalities and lung diseases].

Understanding the principle biophysics concepts of pulmonary surfactant in health and disease

Mechanosensitive Channels TMEM63A and TMEM63B Mediate Lung Inflation-Induced Surfactant Secretion

Clinical Characteristics and Genetic Analysis of Interstitial Lung Disease in Chinese Children (Genes and Interstitial Lung Disease)

Depressed exocytosis and endocytosis of type II alveolar epithelial cells are responsible for the surfactant deficiency in the lung of newborn with congenital diaphragmatic hernia.

Surfactant protein disorders in childhood interstitial lung disease

Pulmonary surfactant metabolism dysfunction: A pediatric clinical case report

Role of Pulmonary Surfactants in Acute Respiratory Distress Syndrome

Surfactant Proteins in Smoking-Related Lung Disease

Human surfactant protein B: structure, function, regulation, and genetic disease

Research advances in the composition and function of pulmonary surfactant

Genetic Basis of Surfactant Dysfunction in Chinese Children: A Retrospective Study.

What is new in synthetic lung surfactant protein technology?

Novel opportunities from bioimaging to understand the trafficking and maturation of intracellular pulmonary surfactant and its role in lung diseases

Potential Therapeutic Applications of Pulmonary Surfactant Lipids in the Host Defence Against Respiratory Viral Infections

Biomarkers in Lung Diseases : from Pathogenesis to Prediction to New Therapies Epithelial disruption of Gab 1 perturbs surfactant homeostasis and predisposes mice to lung injuries

The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases

Study Interactions Between Inhaled Nanoparticles and Pulmonary Surfactant Using Molecular Dynamics Simulations

Pulmonary Surfactant: A Mighty Thin Film

Clinical and genetic spectrum of interstitial lung disease in Chinese children associated with surfactant protein C mutations

ABCA3 mutation-induced congenital pulmonary surfactant deficiency: A case report